期刊文献+

肺动脉高压相关因子的研究进展 被引量:1

Research Progress of Factors Related with Pulmonary Arterial Hypertension
下载PDF
导出
摘要 肺动脉高压(PAH)是一组由异源性疾病和不同发病机制引起的以肺血管阻力持续增加为特征的临床病理生理综合征,其病理变化包括肺血管收缩、细胞增殖、体内血栓形成,发病机制极为复杂,许多环节仍然不明确,有待于深入研究。近年来有关PAH及相关因子方面的研究已成为国内外学术热点,该文通过总结PAH最新研究,以提供临床和基础医学研究的新观点。 Pulmonary arterial hypertension is a clinical-pathological physiological syndrome characterized by persistent excessive vascular resistance and caused by heterologous diseases and different pathogenesis. Its pathological changes include pulmonary vasoconstriction, cell proliferation, and thrombosis. The pathogenesis is extremely complex, and many aspects are still not clear and need in-depth study. In recent years, research on PAH and related factors at home and abroad has become academic hot issue, and here is to summarize the latest research on PAH and provide new points of view of the clinical and basic medical research.
作者 王鹏 赵延恕
出处 《医学综述》 2014年第3期408-411,共4页 Medical Recapitulate
关键词 肺动脉高压 血管收缩 血管重构 Pulmonary arterial hypertension Vascular contraction Vascular remodeling
  • 相关文献

参考文献34

  • 1Schannwell CM, Steiner S, Strauer BE. Diagnostics in pulmonary hypertension[ J ]. J Physiol Pharmacol, 2007,58 Suppl 5 ( Pt 2 ) : 591 -502.
  • 2Eddahibi S, Humbert M, Sediame S, et al. Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Effect of prostacyclin therapy[ J]. Am J Rcspir Crit Care Med ,2000,162 (4 Pt 1 ) :1493- 1499.
  • 3Takeoka M,Ehara T, Sagara J,et al. Calponin hi induced a flat- tened morphology and suppressed the growth of human fibrosarcoma HT1080 cells[ J 1. Eur J Cancer,2002,38 ( 3 ) :436-442.
  • 4Winder SJ,Walsh MP. Calponin:thin filament-linked regulation of smooth muscle contraction [ J ]. Cell Signal. 1993.5 ( 6 ):677-686.
  • 5曹禹,李智,封瑞.肺动脉高压大鼠肺动脉平滑肌上calponin和TGFβ1的变化[J].中国药理学通报,2007,23(2):277-278. 被引量:8
  • 6Sugenoya Y, Yoshimura A, Yamamura H,et al. Smooth-muscle cal- ponin in mesangial ceils ; regulation of expression and a role in sup- pressing glomerulonephritis [ J ]. J Am Soc Nephrol, 2002,13 ( 2 ) : 322-331.
  • 7Horiuchi A, Nikaido T, Taniquchi S, et al. Possible role of calponin hl as a tumor suppressor in human uterine leioms,osarcoma [ J ]. J Natl Cancer Inst, 1999,91 ( 9 ) :790-796.
  • 8Tada Y,Majka S,Carr M,et al. Molecular effects of loss of BMPR2 signaling in smooth muscle in a transgenic mouse model of PAH [J]. Am J Physiol Lung Cell Mol Physiol, 2007, 292 (6): L1556-L1563.
  • 9Fujii T, Yamana K, Ogoma Y, et al. Interaction of calponin with phospholipids [ J ]. J B iochem, 1995,117 ( 5 ) :999-1003.
  • 10Menice CB,Hulvershorn J,Adam LP,et al. Calponin and mitogen- activated protein kinase signaling in differentiated vascular smooth muscle [ J ]. J Biol Chem, 1997,272 ( 40 ) : 25157-25161.

二级参考文献25

共引文献22

同被引文献21

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部